THEM6 and posterior cortical atrophy: The authors validated their findings in PCa patients and found a significant correlation between high THEM6 expression and shortened progression‐free and recurrence‐free survival in both the PRAD TCGA and the MSKCC (Taylor et al, 2010) cohorts.